BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24443139)

  • 1. Structural and antigenic stability of H5N1 hemagglutinin trimer upon release from polyanhydride nanoparticles.
    Ross KA; Loyd H; Wu W; Huntimer L; Wannemuehler MJ; Carpenter S; Narasimhan B
    J Biomed Mater Res A; 2014 Nov; 102(11):4161-8. PubMed ID: 24443139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity.
    Ross KA; Loyd H; Wu W; Huntimer L; Ahmed S; Sambol A; Broderick S; Flickinger Z; Rajan K; Bronich T; Mallapragada S; Wannemuehler MJ; Carpenter S; Narasimhan B
    Int J Nanomedicine; 2015; 10():229-43. PubMed ID: 25565816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres.
    Lopac SK; Torres MP; Wilson-Welder JH; Wannemuehler MJ; Narasimhan B
    J Biomed Mater Res B Appl Biomater; 2009 Nov; 91(2):938-947. PubMed ID: 19642209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular Internalization Mechanisms of Polyanhydride Particles: Implications for Rational Design of Drug Delivery Vehicles.
    Phanse Y; Lueth P; Ramer-Tait AE; Carrillo-Conde BR; Wannemuehler MJ; Narasihan B; Bellaire BH
    J Biomed Nanotechnol; 2016 Jul; 12(7):1544-52. PubMed ID: 29337493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles.
    Haughney SL; Petersen LK; Schoofs AD; Ramer-Tait AE; King JD; Briles DE; Wannemuehler MJ; Narasimhan B
    Acta Biomater; 2013 Sep; 9(9):8262-71. PubMed ID: 23774257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.
    Wafa EI; Geary SM; Goodman JT; Narasimhan B; Salem AK
    Acta Biomater; 2017 Mar; 50():417-427. PubMed ID: 28063991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens.
    Carrillo-Conde B; Schiltz E; Yu J; Chris Minion F; Phillips GJ; Wannemuehler MJ; Narasimhan B
    Acta Biomater; 2010 Aug; 6(8):3110-9. PubMed ID: 20123135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antigenic architecture of the hemagglutinin of influenza H5N1 viruses.
    Velkov T; Ong C; Baker MA; Kim H; Li J; Nation RL; Huang JX; Cooper MA; Rockman S
    Mol Immunol; 2013 Dec; 56(4):705-19. PubMed ID: 23933511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer chemistry influences monocytic uptake of polyanhydride nanospheres.
    Ulery BD; Phanse Y; Sinha A; Wannemuehler MJ; Narasimhan B; Bellaire BH
    Pharm Res; 2009 Mar; 26(3):683-90. PubMed ID: 18987960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated High-Throughput Synthesis of Protein-Loaded Polyanhydride Nanoparticle Libraries.
    Goodman JT; Mullis AS; Dunshee L; Mitra A; Narasimhan B
    ACS Comb Sci; 2018 May; 20(5):298-307. PubMed ID: 29617113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus.
    Chiu FF; Venkatesan N; Wu CR; Chou AH; Chen HW; Lian SP; Liu SJ; Huang CC; Lian WC; Chong P; Leng CH
    Biochem Biophys Res Commun; 2009 May; 383(1):27-31. PubMed ID: 19324009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity and immunological responses following oral vaccination of nanoencapsulated avian influenza virus H5 DNA vaccine with green synthesis silver nanoparticles.
    Jazayeri SD; Ideris A; Zakaria Z; Shameli K; Moeini H; Omar AR
    J Control Release; 2012 Jul; 161(1):116-23. PubMed ID: 22549012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High throughput cell-based screening of biodegradable polyanhydride libraries.
    Adler AF; Petersen LK; Wilson JH; Torres MP; Thorstenson JB; Gardner SW; Mallapragada SK; Wannemuehler MJ; Narasimhan B
    Comb Chem High Throughput Screen; 2009 Aug; 12(7):634-45. PubMed ID: 19531023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine antigenic variation within H5N1 influenza virus hemagglutinin's antigenic sites defined by yeast cell surface display.
    Li J; Wang Y; Liang Y; Ni B; Wan Y; Liao Z; Chan KH; Yuen KY; Fu X; Shang X; Wang S; Yi D; Guo B; Di B; Wang M; Che X; Wu Y
    Eur J Immunol; 2009 Dec; 39(12):3498-510. PubMed ID: 19798682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipocalin-2-loaded amphiphilic polyanhydride microparticles accelerate cell migration.
    Petersen LK; Determan AS; Westgate C; Bendickson L; Nilsen-Hamilton M; Narasimhan B
    J Biomater Sci Polym Ed; 2011; 22(9):1237-52. PubMed ID: 20615357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
    Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction, genetic stability and protective efficacy of recombinant fowlpox virus expressing hemagglutinin gene of H5N1 subtype avian influenza virus].
    Jia L; Peng D; Zhang Y; Liu H; Liu X
    Wei Sheng Wu Xue Bao; 2003 Dec; 43(6):722-7. PubMed ID: 16276892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monovalent H5 vaccine based on epitope-chimeric HA provides broad cross-clade protection against variant H5N1 viruses in mice.
    He F; Prabakaran M; Rajesh Kumar S; Tan Y; Kwang J
    Antiviral Res; 2014 May; 105():143-51. PubMed ID: 24637255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.